Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Hepatitis C

Free Subscription Articles published in J Hepatol Retrieve available abstracts of 161 articles: HTML format Text format

Single Articles

December 2009
1. CLAASSEN MA , de Knegt RJ, Tilanus HW, Janssen HL, et al
   Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis.
   J Hepatol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. CROTTA S , Brazzoli M, Piccioli D, Valiante NM, et al
   Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection.
   J Hepatol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. DAI CY , Ho CK, Huang JF, Hsieh MY, et al
   Hepatitis C virus viremia and low platelet count: A study in a hepatitis B & C endemic area in Taiwan.
   J Hepatol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
4. JOUAN L , Melancon P, Rodrigue-Gervais IG, Raymond VA, et al
   Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 protease.
   J Hepatol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. GRUNHAGE F , Nattermann J, Gressner OA, Wasmuth HE, et al
   Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C.
   J Hepatol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
6. CASTERA L , Sebastiani G, Le Bail B, de Ledinghen V, et al
   Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
   J Hepatol. 2009.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. GRASSO A
   Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: A clarification.
   J Hepatol. 2009.
   PubMed     Text format     Related articles   
   
   
   
8. DONATO C , Cingolani A, Pinnetti C, De Luca A, et al
   Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients.
   J Hepatol. 2009.
   PubMed     Text format     Related articles   
   
   
   
9. WU KT , Yang JF, Chuang WL, Yu ML, et al
   Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: Some issues.
   J Hepatol. 2009.
   PubMed     Text format     Related articles   
   
   
   October 2009
10. MARCELLIN P , Gish RG, Gitlin N, Heise J, et al
    Safety and efficacy of viramidine versus ribavirin in ViSER2: Randomized, double-blind study in therapy-naive hepatitis C patients.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. NAKAMOTO S , Imazeki F, Fukai K, Fujiwara K, et al
    Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. MORENO C , Deltenre P, Pawlotsky JM, Henrion J, et al
    Shortened treatment duration in treatment-naive genotype 1 HCV patients with rapid virological response: A meta-analysis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. SCHAFER A , Scheurlen M, Seufert J, Keicher C, et al
    Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. COBBOLD JF , Patel JH, Goldin RD, North BV, et al
    Hepatic lipid profiling in chronic hepatitis C: An in vitro and in vivo proton magnetic resonance spectroscopy study.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. RUMI MG
    Pegylated interferon alpha2b versus pegylated interferon alpha2a for chronic hepatitis C: The unreached goal of superiority.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. ZEUZEM S
    Forewarned is forearmed.
    J Hepatol. 2009;51:626-7.
    PubMed     Text format     Related articles   
    
    
    September 2009
17. HIRAGA N , Imamura M, Hatakeyama T, Kitamura S, et al
    Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. SAMRI A , Roque-Afonso AM, Beran O, Tateo M, et al
    Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC" trial).
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. HOUGHTON M
    The long and winding road leading to the identification of the hepatitis C virus.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
20. DE NICOLA S , Aghemo A, Rumi MG, Colombo M, et al
    HCV genotype 3: An independent predictor of fibrosis progression in chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
21. CERNY A
    Hepatitis C after simultaneous liver-kidney transplantation.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
22. PARK CY , Choi SH, Kang SM, Kang JI, et al
    Nonstructural 5A protein activates beta-catenin signaling cascades: Implication of hepatitis C virus-induced liver pathogenesis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. GIRELLI D , Pasino M, Goodnough JB, Nemeth E, et al
    Reduced serum hepcidin levels in patients with chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. CARRION JA , Navasa M, Forns X
    Antiviral therapy in HCV-infected cirrhotic patients awaiting liver transplantation.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    July 2009
25. WANG B , Trippler M, Pei R, Lu M, et al
    Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis c virus replication.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. GRASSO A , Malfatti F, Leo PD, Martines H, et al
    Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. REESINK HW , Weegink CJ
    New hope for a cure for chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. GREBELY J , Thomas DL, Dore GJ
    HCV reinfection studies and the door to vaccine development.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
29. CAMMA C , Cabibbo G, Bronte F, Enea M, et al
    Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. BALFE P , McKeating JA
    The complexities of hepatitis C virus entry.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. WEILAND O
    What offers the best prediction of sustained virologic response during combination therapy with interferon and ribavirin: viral dynamics, viral levels at certain time points, or a combination of both?
    J Hepatol. 2009;51:4-7.
    PubMed     Text format     Related articles   
    
    
    June 2009
32. NIEMCZYK M , Krawczyk M, Paczek L
    Antiviral therapy preceding liver transplantation in HCV cirrhosis - Still too many doubts.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
33. MANSILLA C , Gorraiz M, Martinez M, Casares N, et al
    Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. LI Y , Chang M, Abar O, Garcia V, et al
    Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. VAN DE LAAR TJ , Molenkamp R, van den Berg C, Schinkel J, et al
    Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. VAN WAGNER LB , Baker T, Ahya SN, Norvell JP, et al
    Outcomes of patients with hepatitis C undergoing simultaneous liver-kidney transplantation.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. BOCHUD PY , Cai T, Overbeck K, Bochud M, et al
    Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. EYRE NS , Phillips RJ, Bowden S, Yip E, et al
    Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
39. BARTOSCH B , Thimme R, Blum HE, Zoulim F, et al
    Hepatitis C virus-induced hepatocarcinogenesis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. PFEFFER S , Baumert TF
    Unravelling the importance of microRNAs during hepatitis C virus infection in the human liver.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
41. COOPER C , Lawitz EJ, Ghali P, Rodriguez-Torres M, et al
    Evaluation of VCH-759 monotherapy in hepatitis C infection.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. WEGERT M , Monica NL, Tripodi M, Adler G, et al
    Impaired interferon type I signalling in the liver modulates the hepatic acute phase response in hepatitis C virus transgenic mice.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. ZHANG YL , Guo YJ, Bin Li, Sun SH, et al
    Hepatitis C virus single-stranded RNA induces innate immunity via Toll-like receptor 7.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
44. FERRI S , Muratori L, Quarneti C, Muratori P, et al
    Clinical features and effect of antiviral therapy on anti-liver/kindey microsomal antibody type 1 positive chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. RAIMONDI S , Bruno S, Mondelli MU, Maisonneuve P, et al
    Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. DE VOS R , Verslype C, Depla E, Fevery J, et al
    WITHDRAWN: Ultrastructural visualization of hepatitis C virus components in human and primate liver biopsies.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. BARTOSCH B
    Hepatitis C virus and its complex interplay with the hepatic glucose and lipid metabolism.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
48. NEGRO F
    Correction of insulin resistance in chronic hepatitis C patients not responding to the standard of care: More questions than answers.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
49. SERFATY L , Fartoux L, Poupon R
    Pioglitazone as adjuvant therapy in chronic hepatitis C: Sequential rather than concomitant administration with pegylated interferon and ribavirin?
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
50. NEUMANN AU , Pianko S, Zeuzem S, Yoshida EM, et al
    Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naive patients with genotype 1, chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
51. KASAI D , Adachi T, Deng L, Nagano-Fujii M, et al
    HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. VLIEGEN I , Paeshuyse J, Burghgraeve TD, Lehman LS, et al
    Substituted imidazopyridines as potent inhibitors of HCV replication.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. DIONISIO N , Garcia-Mediavilla MV, Sanchez-Campos S, Majano PL, et al
    Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. HUANG YH , Wu JC, Peng WL, Huo TI, et al
    Generation of cytotoxicity against hepatitis delta virus genotypes and quasispecies by epitope modification.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. KIM KA , Lin W, Tai AW, Shao RX, et al
    Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. ROCHE B , Samuel D
    Antiviral therapy in HCV-infected cirrhotics awaiting liver transplantation: A costly strategy for mixed virological results.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
57. SULKOWSKI M
    Hepatocellular carcinoma in HIV-infected patients comes of age: The convergence of epidemiology and treatment effectiveness.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
58. DAI CY , Huang JF, Hsieh MY, Hou NJ, et al
    Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
59. CAMMA C , Petta S
    Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the future.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
60. MARRERO JA
    Modern diagnosis of hepatocellular carcinoma: Utilization of liver biopsy and genomic markers.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    January 2009
61. SAUTER D , Himmelsbach K, Kriegs M, Yepes MC, et al
    Localization determines function: N-terminally truncated NS5A fragments accumulate in the nucleus and impair HCV replication.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. WESESLINDTNER L , Neumann-Haefelin C, Viazov S, Haberstroh A, et al
    Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variability.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. KUMADA T , Toyoda H, Kiriyama S, Sone Y, et al
    Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. SALMON-CERON D , Rosenthal E, Lewden C, Bouteloup V, et al
    Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalite 2005 study.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. BEDOSSA P , Carrat F
    Liver biopsy: the best, not the gold standard.
    J Hepatol. 2009;50:1-3.
    PubMed     Text format     Related articles   
    
    
    
66. MEHTA SH , Lau B, Afdhal NH, Thomas DL, et al
    Exceeding the limits of liver histology markers.
    J Hepatol. 2009;50:36-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    December 2008
67. CARRION JA , Martinez-Bauer E, Crespo G, Ramirez S, et al
    Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. MERCHANTE N , de Los Santos-Gil I, Merino D, Gonzalez-Serrano M, et al
    Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. KIM SI , Shin D, Lee H, Ahn BY, et al
    Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. PIETSCHMANN T
    Regulation of hepatitis C virus replication by microRNAs.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    
71. HUANG JF , Dai CY, Yu ML, Shin SJ, et al
    Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. CHOLONGITAS E , Manousou P, Samonakis D, Burroughs AK, et al
    Progression of HCV infection in patients with chronic kidney disease.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    
73. MARTIN P , Fabrizi F
    Progression of HCV infection in patients with chronic kidney disease: Reply.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    
74. GOZLAN J , Lacombe K, Gault E, Raguin G, et al
    Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. BERRES ML , Papen S, Pauels K, Schmitz P, et al
    A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. GIANNINI EG , Savarino V
    HCV and fat: Something is missing.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    
77. DAI CY , Chuang WL, Ho CK, Yu ML, et al
    Hepatitis C viremia and serum lipid levels: A clue from an epidemiology study.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    
78. REDDY KR , Nelson DR, Zeuzem S
    Ribavirin: Current role in the optimal clinical management of chronic hepatitis C.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. TAI AW , Chung RT
    Treatment failure in hepatitis C: Mechanisms of non-response.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
80. MICHALAK TI , Pham TN
    Anti-HCV core antibody: A potential new marker of occult and otherwise serologically silent HCV infection.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    November 2008
81. VARCHETTA S , Oliviero B, Francesca Donato M, Agnelli F, et al
    Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. MIHM U , Ackermann O, Welsch C, Herrmann E, et al
    Clinical relevance of the 2'-5'-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis C.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. WEDEMEYER I , Bechmann LP, Odenthal M, Jochum C, et al
    Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: Therapeutic implications for hepatitis C.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. SCHUSTER C , Baumert TF
    EWI-2wint - A host cell factor inhibiting hepatitis C virus entry.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. THOMPSON A , Patel K, Tillman H, McHutchison JG, et al
    Directly acting antivirals for the treatment of patients with hepatitis C infection: A clinical development update addressing key future challenges.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. QUIROGA JA , Castillo I, Llorente S, Bartolome J, et al
    Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. KIM E , Li K, Lieu C, Tong S, et al
    Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis.
    J Hepatol. 2008;49:787-98.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2008
88. EUROPEAN ASSOCIATION FOR THE S
    EASL Clinical Practice Guidelines: Management of chronic hepatitis B.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    
89. CASTERA L , Bail BL, Roudot-Thoraval F, Bernard PH, et al
    Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. FORNS X
    Role of nosocomial hospital transmission in acute hepatitis C: Reply.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    
91. MORIN T , Pariente A, Cadranel JF, Denis J, et al
    Role of nosocomial hospital transmission in acute hepatitis C.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    
92. HASSAN MM , Spitz MR, Thomas MB, Curley SA, et al
    The association of family history of liver cancer with hepatocellular carcinoma: A case-control study in the United States.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. MACIAS J , Recio E, Vispo E, Rivero A, et al
    Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
94. ALBERT ML , Decalf J, Pol S
    Plasmacytoid dendritic cells move down on the list of suspects: In search of the immune pathogenesis of chronic hepatitis C.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. TEUBER G , Schafer A, Rimpel J, Paul K, et al
    Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: Association with demographic factors, inflammatory activity, and degree of fibrosis.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. TSAI YH , Kuang WF, Lu TY, Kao JH, et al
    The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. GRIFFIN S , Trowbridge R, Thommes P, Parry N, et al
    Chimeric GB virus B genomes containing hepatitis C virus p7 are infectious in vivo.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2008
98. WHITE DL , Ratziu V, El-Serag HB
    Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis.
    J Hepatol. 2008.
    PubMed     Text format     Related articles    Abstract available
    
    
    
99. RAIMONDO G , Saitta C
    Treatment of the hepatitis B virus and hepatitis C virus co-infection: Still a challenge for the hepatologist.
    J Hepatol. 2008.
    PubMed     Text format     Related articles   
    
    
    
100. SILVA MO
     Compare trial: updated data.
     J Hepatol. 2008;49:288-9.
     PubMed     Text format     Related articles   
     
     
     July 2008
101. KAU A , Vermehren J, Sarrazin C
     Treatment predictors of a sustained virologic response in hepatitis B and C.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. PAGGI S , Colli A, Fraquelli M, Vigano M, et al
     A non-invasive algorithm accurately predicts advanced fibrosis in hepatitis C: A comparison using histology with internal-external validation.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. LA MURA V , Renzo AD, Perna F, D'Agostino D, et al
     Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. SELZNER N , McGilvray I
     Can genetic variations predict HCV treatment outcomes?
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
105. GARATTINI S
     Is there discrimination in access to therapy for HCV patients?
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
106. SANTANTONIO T , Wiegand J, Tilman Gerlach J
     Acute hepatitis C: Current status and remaining challenges.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. PIROTH L , Carrat F, Larrat S, Goderel I, et al
     Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. MCPHERSON S , Jonsson JR, Barrie HD, O'Rourke P, et al
     Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. GHEORGHE L , Iacob S, Csiki IE
     Prevalence of hepatitis C in Romania: Different from European rates?
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
110. QUER J , Esteban JI, Sauleda S
     Prevalence of hepatitis C in Romania: Different from European rates? Reply.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
111. MURAKAMI Y , Aly HH, Tajima A, Inoue I, et al
     Regulation of the hepatitis C virus genome replication by miR-199a.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
112. TOGASHI H , Hashimoto C, Yokozawa J, Suzuki A, et al
     What can be revealed by extending the sensitivity of HBsAg detection to below the present limit?
     J Hepatol. 2008;49:17-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2008
113. RENDINA M , Schena A, Schena FP, Francavilla A, et al
     Acute rejection of non-functional allograft in kidney transplant recipients with hepatitis C treated with peginterferon alpha-2a: Reply.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
114. SPERL J , Petrasek J, Spicak J, Viklicky O, et al
     Acute rejection of non-functional allograft in kidney transplant recipients with hepatitis C treated with peginterferon-alpha2a.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
115. MATTHEWS GV , Grebely J, Dore GJ
     The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposure.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
116. MARTIN P , Fabrizi F
     Hepatitis C virus and kidney disease.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
117. HALANGK J , Sarrazin C, Neumann K, Puhl G, et al
     Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. BURTON JR JR , Klarquist J, Im K, Smyk-Pearson S, et al
     Prospective analysis of effector and regulatory CD4(+) T cells in chronic HCV patients undergoing combination antiviral therapy.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. FUJITA N , Sugimoto R, Motonishi S, Tomosugi N, et al
     Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
120. CHEN W , Wong T, Tomlinson G, Krahn M, et al
     Prevalence and predictors of obesity among individuals with positive hepatitis C antibody in a tertiary referral clinic.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. MORGAN TR , Lambrecht RW, Bonkovsky HL, Chung RT, et al
     DNA polymorphisms and response to treatment in patients with chronic hepatitis C: Results from the HALT-C trial.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. LETTMEIER B , Muhlberger N, Schwarzer R, Sroczynski G, et al
     Market uptake of new antiviral drugs for the treatment of hepatitis C.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2008
123. RIBES J , Cleries R, Esteban L, Moreno V, et al
     The influence of alcohol consumption and hepatitis B and C infections on the risk of liver cancer in Europe.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. BURIONI R , Perotti M, Mancini N, Clementi M, et al
     Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. OVERBECK K , Genne D, Golay A, Negro F, et al
     Pioglitazone in chronic hepatitis C not responding to pegylated interferon-alpha and ribavirin.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. ZEUZEM S
     Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles   
     
     
     
127. BERENGUER M
     Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
128. DEUFFIC-BURBAN S , Deltenre P, Louvet A, Canva V, et al
     Impact of viral eradication on mortality related to hepatitis C: A modeling approach in France.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. SU X , Yee LJ, Im K, Rhodes SL, et al
     Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
130. LIBRA M , Gloghini A, Malaponte G, Gangemi P, et al
     In gastrointestinal mucosa-associated lymphoid tissue lymphomas t(14;18)-(IgH/Bcl-2) translocation clusters in hepatitis C virus-infected patients.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
131. SHORES NJ , Maida I, Soriano V, Nunez M, et al
     Sexual transmission is associated with spontaneous HCV clearance in HIV-infected patients.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. CASTERA L , Forns X, Alberti A
     Non-invasive evaluation of liver fibrosis using transient elastography.
     J Hepatol. 2008;48:835-47.
     PubMed     Text format     Related articles    Abstract available
     
     
     
133. SEBASTIANI G , Alberti A
     Implementing non-invasive markers for liver fibrosis in clinical practice.
     J Hepatol. 2008;48:880-1.
     PubMed     Text format     Related articles   
     
     
     April 2008
134. BERNSMEIER C , Duong FH, Christen V, Pugnale P, et al
     Virus induced over-expression of protein phosphatase 2A inhibits insulin signalling in chronic hepatitis C.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. POTTHOFF A , Wedemeyer H, Boecher WO, Berg T, et al
     The HEP-NET B/C co-infection trial: A prospective multicenter study to investigate the efficacy of pegylated interferon-alpha2b and ribavirin in patients with HBV/HCV co-infection.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. LAWITZ E , Rodriguez-Torres M, Muir AJ, Kieffer TL, et al
     Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
137. ANDRE P , Lotteau V
     Hepatitis C virus assembly: When fat makes it easier.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. FORTON DM , Hamilton G, Allsop JM, Grover VP, et al
     Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
139. DAI CY , Chuang WL, Ho CK, Hsieh MY, et al
     Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: A community-based study.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
140. BARTH H , Robinet E, Liang TJ, Baumert TF, et al
     Mouse models for the study of HCV infection and virus-host interactions.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. PEFFAULT DE LATOUR R , Ribaud P, Robin M, Valla D, et al
     Allogeneic hematopoietic cell transplant in HCV-infected patients.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     March 2008
142. FORNS X , Sanchez-Tapias JM, Bruguera M
     Nosocomial acquisition of the hepatitis C virus.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles   
     
     
     
143. PUGNALE P , Herrmann E, Neumann AU, Pawlotsky JM, et al
     Hepatitis C viral kinetics in plasma and peripheral blood mononuclear cells during pegylated interferon-alpha2a/ribavirin therapy.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
144. DETERDING K , Wiegand J, Gruner N, Wedemeyer H, et al
     Medical procedures as a risk factor for HCV infection in developed countries: Do we neglect a significant problem in medical care?
     J Hepatol. 2008;.
     PubMed     Text format     Related articles   
     
     
     
145. KAPLAN DE , Ikeda F, Li Y, Nakamoto N, et al
     Peripheral virus-specific T-cell interleukin-10 responses develop early in acute hepatitis C infection and become dominant in chronic hepatitis.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. BROERING R , Wu J, Meng Z, Hilgard P, et al
     Toll-like receptor-stimulated non-parenchymal liver cells can regulate hepatitis C virus replication.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     February 2008
147. SELZNER N , Chen L, Borozan I, Edwards A, et al
     Hepatic gene expression and prediction of therapy response in chronic hepatitis C patients.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. SAMUEL D , Weber R, Stock P, Duclos-Vallee JC, et al
     Are HIV-infected patients candidates for liver transplantation?
     J Hepatol. 2008;.
     PubMed     Text format     Related articles   
     
     
     
149. KUROSAKI M , Matsunaga K, Hirayama I, Tanaka T, et al
     The presence of steatosis and elevation of alanine aminotransferase levels are associated with fibrosis progression in chronic hepatitis C with non-response to interferon therapy.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
150. CACOUB P , Carrat F, Bedossa P, Lambert J, et al
     Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: The fibrovic study - ANRS HC02.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. LEROY V , Zarski JP
     Clinical applicability of non-invasive markers for liver fibrosis in chronic hepatitis C.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles   
     
     
     
152. RODRIGUEZ-TORRES M , Govindarajan S, Sola R, Clumeck N, et al
     Hepatic steatosis in HCV/HIV co-infected patients: Correlates, efficacy and outcomes of anti-HCV therapy: A paired liver biopsy study.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     January 2008
153. NEWELL P , Villanueva A, Friedman SL, Koike K, et al
     Experimental models of hepatocellular carcinoma.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
154. URBANI S , Amadei B, Tola D, Pedrazzi G, et al
     Restoration of HCV-specific T cell functions by PD-1/PD-L1 blockade in HCV infection: Effect of viremia levels and antiviral treatment.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
155. MALLAT A , Hezode C, Lotersztajn S
     Environmental factors as disease accelerators during chronic hepatitis C.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. ROMERO-GOMEZ M , Fernandez-Rodriguez CM, Andrade RJ, Diago M, et al
     Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. POPOV Y , Patsenker E, Stickel F, Zaks J, et al
     Integrin alphavbeta6 is a marker of the progression of biliary and portal liver fibrosis and a novel target for antifibrotic therapies.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2007
158. VALENTI L , Dongiovanni P, Fargion S, Fracanzani AL, et al
     Iron genes, dysmetabolism and fibrosis in chronic hepatitis C.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles   
     
     
     
159. LUPBERGER J , Brino L, Baumert TF
     RNAi - A powerful tool to unravel hepatitis C virus-host interactions within the infectious life cycle.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. SULKOWSKI MS
     Viral hepatitis and HIV coinfection.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     
     November 2007
161. SCOTTA C , Garbuglia AR, Ruggeri L, Spada E, et al
     Influence of specific CD4+ T cells and antibodies on evolution of hypervariable region 1 during acute HCV infection.
     J Hepatol. 2007;.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: